Identification of key differentially expressed genes between ER-positive/HER2-negative breast cancer and ER-negative/HER2-negative breast cancer using integrated bioinformatics analysis

BACKGROUND: Treatment strategies for various subtypes of breast cancer (BC) are different based on their distinct molecular characteristics. Therefore, it is very important to identify key differentially expressed genes (DEGs) between ER-positive/HER2-negative BC and ER-negative/HER2-negative BC. ME...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Gland Surg
Główni autorzy: Gan, Siyuan, Dai, Haixia, Li, Rujia, Liu, Wang, Ye, Ruifang, Ha, Yanping, Di, Xiaoqing, Hu, Wenhua, Zhang, Zhi, Sun, Yanqin
Format: Artigo
Język:Inglês
Wydane: AME Publishing Company 2020
Hasła przedmiotowe:
Original Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7347802/
https://ncbi.nlm.nih.gov/pubmed/32775256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/gs.2020.03.40
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy